These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33415422)

  • 1. Hematologic disorders associated with COVID-19: a review.
    Rahi MS; Jindal V; Reyes SP; Gunasekaran K; Gupta R; Jaiyesimi I
    Ann Hematol; 2021 Feb; 100(2):309-320. PubMed ID: 33415422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities.
    Shama ; Mahmood A; Mehmood S; Zhang W
    Curr Issues Mol Biol; 2023 Aug; 45(9):7161-7182. PubMed ID: 37754237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic Complications of COVID-19 Infection: A Review.
    Castro RA; Frishman WH
    Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19.
    Mei H; Luo L; Hu Y
    J Hematol Oncol; 2020 Dec; 13(1):161. PubMed ID: 33261634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.
    Manzoor D; Bui C; Makhoul E; Luthringer D; Marchevsky A; Volod O
    Medicine (Baltimore); 2021 Apr; 100(15):e25255. PubMed ID: 33847623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The looming storm: Blood and cytokines in COVID-19.
    Kaur S; Bansal R; Kollimuttathuillam S; Gowda AM; Singh B; Mehta D; Maroules M
    Blood Rev; 2021 Mar; 46():100743. PubMed ID: 32829962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
    Agbuduwe C; Basu S
    Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
    Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
    Lohse A; Klopfenstein T; Balblanc JC; Royer PY; Bossert M; Gendrin V; Charpentier A; Bozgan AM; Badie J; Bourgoin C; Contreras R; Mazurier I; Conrozier T; Zayet S
    Microbes Infect; 2020 Oct; 22(9):500-503. PubMed ID: 32574789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic parameters and biomarkers predictors of severity in Multisystem Inflammatory Syndrome in children associated with SARS-CoV-2.
    Verdugo P; Álvarez P; Aroca P; Montes V; Poli C; Tapia L; Cofré F; Soto V; Mackenney J; Carvajal C; Acevedo V
    Andes Pediatr; 2021 Jun; 92(3):382-388. PubMed ID: 34479244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematological Abnormalities in COVID-19: A Narrative Review.
    Rahman A; Niloofa R; Jayarajah U; De Mel S; Abeysuriya V; Seneviratne SL
    Am J Trop Med Hyg; 2021 Feb; 104(4):1188-1201. PubMed ID: 33606667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major coagulation disorders and parameters in COVID-19 patients.
    Teimury A; Khameneh MT; Khaledi EM
    Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
    Hong LZ; Shou ZX; Zheng DM; Jin X
    Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and anticoagulation in COVID-19.
    Hadid T; Kafri Z; Al-Katib A
    Blood Rev; 2021 May; 47():100761. PubMed ID: 33067035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of COVID-19 Disease on Platelets and Coagulation.
    Wool GD; Miller JL
    Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.
    Siddiqui SN; Jayasekhar R; Tshering S; Jugjali R; Shanmugavadivel D; Jawed A; Rahman MM
    Int J Infect Dis; 2021 Mar; 104():568-571. PubMed ID: 33486013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.